Profile of Functional Constipation in Children at a Referral Hospital

Vikas Arvindbhai Makhwana1, Kakoli Acharyya1, Saugata Acharyya2

  • 1Department of Pediatrics, Calcutta Medical Research Institute, Kolkata, West Bengal.

Indian Pediatrics
|January 11, 2022
PubMed

Insights

Functional constipation (FC) affects 5.56% of pediatric hospital attendees, with painful defecation being a common symptom. Most children with FC also experience fecal impaction, highlighting the need for effective management strategies.

Area of Science:

  • Pediatric Gastroenterology
  • Clinical Pediatrics
  • Digestive Health

Background:

  • Functional constipation (FC) is a prevalent condition in children.
  • Understanding the profile of FC is crucial for effective diagnosis and management.
  • Previous studies have varied in their focus on demographic and clinical aspects.

Purpose of the Study:

  • To investigate the social, demographic, and clinical characteristics of functional constipation in pediatric patients.
  • To determine the prevalence of FC among children presenting at a tertiary care hospital.
  • To identify common symptoms and precipitating factors associated with FC in children.

Main Methods:

  • A cross-sectional study was conducted.
  • Data were collected from 1565 children aged 1-18 years at a tertiary care hospital.
  • Rome IV diagnostic criteria were used to diagnose functional constipation.

Main Results:

  • Functional constipation (FC) was diagnosed in 5.56% of pediatric hospital attendees.
  • The majority of affected children (64.4%) were aged 2-6 years.
  • Painful defecation (62.1%) was the most frequent symptom, and fecal impaction was present in 70.1% of cases.

Conclusions:

  • Functional constipation is the leading cause of constipation in children.
  • A significant proportion of children with FC present with fecal impaction.
  • Early identification and intervention are essential for managing FC and its complications in pediatric populations.
Abstract

Related Concept Videos

Assessment of the Rectum and Anus01:25

Assessment of the Rectum and Anus

Evaluating the rectum and anus plays a crucial role in conducting a thorough physical examination of the gastrointestinal system. Although it may be uncomfortable and often embarrassing for the patient, it holds immense diagnostic value, particularly in detecting gastrointestinal diseases and abnormalities. This guide will explain how to perform this assessment using inspection and palpation methods.
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
484
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
264
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
557
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
371
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
12
Imaging Studies III: Gastrointestinal Motility Studies and Virtual Colonoscopy01:26

Imaging Studies III: Gastrointestinal Motility Studies and Virtual Colonoscopy

This lesson explores three gastrointestinal imaging techniques: radionuclide testing, colonic transit studies, and virtual colonoscopy.
Radionuclide Testing
Radionuclide testing is a sophisticated medical technique for assessing gastrointestinal motility. It focuses on gastric emptying and colonic transit time. Radioactive markers track the movement of food through the digestive system, providing insights into gastrointestinal disorders.
In gastric emptying studies, a meal's liquid and...
169